Affiliation:
1. Department of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan, P.O. Box 130 Amman 11733,Jordan
2. Department of Chemistry, The University of Jordan, Amman 11942,Jordan
3. DSC 362, Department of Chemistry, The University of Nebraska at Omaha, 6001 Dodge Street, Omaha, Nebraska 68182,United States
Abstract
Background:
Drugs incorporating heterocyclic chemical skeletons possess a plethora of therapeutic activities
such as anticancer, antimicrobial, antihypertensive, and antipsychiatric effects. It is becoming routine, nowadays, to use
cheminformatics and bioinformatics methods to elucidate the mechanism(s) of action of such drugs.
Objective:
To probe the activity of a recently published series of N1-(anthraquinon-2-yl) amidrazone piperazine derivatives
employing computational strategies[1], identify their structural basis of binding to BCR/ABL kinase domain, and explain
their anticancer activities in human breast adenocarcinoma (MCF-7) and chronic myelogenous leukemia (K562) cell lines.
Methods:
We applied an in silico integrative informatics approach integrating molecular descriptors, docking studies,
cheminformatics, and network analysis.
Results:
Our results highlighted the possible involvement of the BCR/ABL and DRD2 pathways in the anticancer activity
of the studied compounds, and induced fit docking (IFD) indicated that the BCR/ABL kinase domain is a putative drug
target. Additionally, high-scoring docking poses identified a unique network of hydrogen bonding with amino acids Y253,
K271, E286, V299, L301, T315, M318, I360, R362, V379, and D3810.
Conclusion:
Using an integrative informatics approach to characterize our anticancer compounds, we were able to explain
the biological differences between synthesized and biologically validated amidrazone piperazine anticancer agents. We
were also able to postulate a mechanism of action of this novel group of anticancer agents.
Funder
Al-Zaytoonah University of Jordan Deanship of Scientific Research and Graduate Studies
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,Molecular Medicine,General Medicine
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献